Medikamentöse Therapie der chronischen Hepatitis B

Eberhard Renner and Daniel Lavanchy

International Journal of Public Health, 1998, vol. 43, issue 1, S21-S23

Abstract: Medical therapy of chronic hepatitis B aims at halting progression towards cirrhosis/hepatocellular carcinoma by inhibiting replication of hepatitis B virus in a sustained fashion (viral elimination). The sole therapy of proven efficacy is interferon-alpha (5–10 Mio IU sc TIW) which leads within 4 months to viral elimination (seroconversion from HBeAg to anti-HBe-antibody; serum HBV-DNA negative by hybridisation) in approximatively 40% of patients. Interferon-alpha therapy has been shown to decrease hepatitis B associated morbiditylmortality and to be cost-effective. Certain nucleoside analoga such as lamivudine or famciclovir are able to stop hepatitis B virus replication in a large proportion of patients; replication promptly resumes however after cessation of treatment and resistance develops in approximatively 15% of patients treated for one year. The clinical value, in particular for interferon-alpha non-responders, of a combination of interferon-alpha and/or nucleoside analoga remains to be seen. Copyright Birkhäuser Verlag 1998

Date: 1998
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://hdl.handle.net/10.1007/BF02042168 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:ijphth:v:43:y:1998:i:1:p:s21-s23

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/00038

DOI: 10.1007/BF02042168

Access Statistics for this article

International Journal of Public Health is currently edited by Thomas Kohlmann, Nino Künzli and Andrea Madarasova Geckova

More articles in International Journal of Public Health from Springer, Swiss School of Public Health (SSPH+)
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().